Podcast Episodes
Back to SearchNavigating HER2+ Early Breast Cancer: Diagnosis, Treatment Planning, and De-Escalation
Episode 475
Drs. Tiffany A. Traina and Claudine Isaacs discuss how they approach HER2+ early breast cancer treatment planning and which patients can take advanta…
1 year, 6 months ago
Navigating HER2+ Early Breast Cancer: When to Use Neoadjuvant Therapies, Addressing Residual Disease, and Potential Treatment Toxicities
Episode 476
Drs. Traina and Isaacs share how they determine which patients are appropriate for neoadjuvant therapies and how to address residual disease, as well…
1 year, 6 months ago
Why are measles outbreaks surging in Texas and New Mexico?
Episode 474
Measles cases are rising in Texas and New Mexico, with most infections occurring in unvaccinated individuals and public health officials warning of f…
1 year, 6 months ago
Specialist Spotlight: Parental favoritism and its impact on family dynamics and mental health
Episode 473
Professor Alexander Jensen discusses parental favoritism and its impact on family dynamics, highlighting that both mothers and fathers tend to favor …
1 year, 6 months ago
Specialist Spotlight: Marlie Tondac investigating learning and attention in young children.
Episode 472
This podcast features Marlie Tondac, the lead author of a study on learning and attention in young children finding that children aged 7 to 9 learn d…
1 year, 6 months ago
Can a urine test reduce unnecessary prostate biopsies?
Episode 471
A study in The Journal of Urology highlighted the potential of the MyProstateScore 2.0 (MPS2) urine test to reduce unnecessary prostate biopsies by u…
1 year, 6 months ago
Could immunotherapy redefine treatment for Estrogen Receptor positive/HER2 negative breast cancer?
Episode 470
A new phase 3 trial demonstrated that adding nivolumab to adjuvant chemotherapy significantly improves outcomes for patients with ER-positive HER2-ne…
1 year, 6 months ago
Approaching Tough Discussions in ILDs: Lung Transplantation and End-of-Life Issues
Episode 469
Drs. Solomon and Swigris review how they discuss lung transplantation with patients with ILDs, as well their philosophies of addressing end-of-life i…
1 year, 6 months ago
Could a fully human monoclonal antibody reduce bleeding risk in atrial fibrillation patients?
Episode 467
A study in NEJM shows that abelacimab, a fully human monoclonal antibody targeting factor XI, significantly reduces bleeding risk compared to rivarox…
1 year, 6 months ago
Insights Into Managing Comorbidities, Discussing Quality of Life, and Benefits of Pulmonary Rehab in Patients With ILDs
Episode 468
Drs. Solomon and Swigris focus on the importance of managing comorbidities and addressing treatment-related adverse events, such as GERD and mood dis…
1 year, 6 months ago